Somatropin(Human Growth Hormone)
- Generic Name
- Somatropin(Human Growth Hormone)
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
⑴各种原因引起的生长激素缺乏性侏儒，包括垂体病变及其下丘脑病变所致者；
⑵儿童其他原因引起的矮小症，如特纳综合征，小于胎龄儿等；
⑶成人生长激素缺乏症、儿童特发性矮小等一些国家已批准使用；
⑷烧伤、儿童慢性肾衰等；
⑸用于Prader-Will综合征；【美国FDA已批准重组人生长激素注射液用于Prader-Will综合征；中华医学会儿科学分会内分泌遗传代谢学组《中华儿科杂志》编辑委员会，《基因重组人生长激素儿科临床规范应用的建议》（2013）】
...
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 162
- Registration Number
- NCT06007417
- Locations
- 🇺🇸
Cook Childrens, Fort Worth, Texas, United States
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 221
- Registration Number
- NCT05308927
- Locations
- 🇫🇷
Novo Nordisk Investigational Site, Toulouse cedex 9, France
Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
- Conditions
- Interventions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 434
- Registration Number
- NCT04513171
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College of HUST, Wuhan, Hubei, China
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT03874013
- Locations
- 🇯🇵
Fukuyama City Hospital, Fukuyama, Hiroshima, Japan
🇯🇵Hospital of the University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
🇯🇵National Hospital Organization Kure Medical Center & Chugoku Cancer Center, Kure, Hiroshima, Japan
Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 87
- Registration Number
- NCT03831880
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇸🇰Národný ústav detských chorôb, Detská klinika, Bratislava, Slovakia
🇺🇸Shriners Hospitals for Children, Tampa, Florida, United States
Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Genexine, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT03309891
- Locations
- 🇺🇦
Odessa National Medical University, Odessa Regional Children's Hospital, Odessa, Ukraine
Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 22
- Registration Number
- NCT03288103
- Locations
- 🇺🇸
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
- Conditions
- Interventions
- First Posted Date
- 2017-03-09
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 62
- Registration Number
- NCT03075644
- Locations
- 🇯🇵
Novo Nordisk Investigational Site, Yokohama, Kanagawa, Japan
A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Genexine, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT02946606
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- Göteborg University
- Target Recruit Count
- 99
- Registration Number
- NCT02879747
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.